(Q88985835)

English

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

scientific article published on 04 June 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

0 references

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

28

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

W. Kimryn Rathmell

13

object named as

W Kimryn Rathmell

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Toni K Choueiri

22

object named as

Toni K Choueiri

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

David F McDermott

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Mahrukh A Huseni

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Michael B Atkins

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Robert J Motzer

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Brian I Rini

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Bernard Escudier

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Lawrence Fong

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Richard W Joseph

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Sumanta K Pal

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

James A Reeves

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Mario Sznol

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

John Hainsworth

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Walter M Stadler

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Thomas Hutson

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Martin E Gore

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Sergio Bracarda

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Cristina Suárez

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Riccardo Danielli

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Viktor Gruenwald

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Dorothee Nickles

23

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Suchit Jhunjhunwala

24

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Elisabeth Piault-Louis

25

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Alpa Thobhani

26

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Jiaheng Qiu

27

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Priti S Hegde

29

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Christina Schiff

30

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Gregg D Fine

31

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Thomas Powles

32

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

publication date

4 June 2018

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Nature Medicine

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

24

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

749-757

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-L1 expression in nonclear-cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 and its ligands in tolerance and immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune effects of bevacizumab: killing two birds with one stone

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus ipilimumab in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The pro- and anti-inflammatory properties of the cytokine interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC).

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The CXCL8-CXCR1/2 pathways in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and genetic properties of tumors associated with local immune cytolytic activity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fast and SNP-tolerant detection of complex variants and splicing in short reads

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

GMAP and GSNAP for Genomic Sequence Alignment: Enhancements to Speed, Accuracy, and Functionality

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Software for computing and annotating genomic ranges

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

limma powers differential expression analyses for RNA-sequencing and microarray studies

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Ensembl Variant Effect Predictor

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

NetMHCcons: a consensus method for the major histocompatibility complex class I predictions

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0053-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/S41591-018-0053-3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29867230%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q88985835&oldid=2139554223"